spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Revivent TC 

 HSMN NewsFeed - 13 Apr 2023
BioVentrix(R) Closes $48.5 Million Series A Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 24 Jan 2023
FDA Agrees to Expanded Access Program for the BioVentrix(R) Revivent TC(R) System for the Treatment of Ischemic Heart Failure
Devices Cardiology FDA
 HSMN NewsFeed - 16 Sep 2019
BioVentrix Announces the Appointment of Pedro Marques as VP of Sales in Europe
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 6 Aug 2019
BioVentrix Announces Key Additions to Leadership Team
Devices Cardiology Personnel
 HSMN NewsFeed - 4 Oct 2017
BioVentrix Announces First Patient Enrolled in the U.S. arm of IDE Study of the Revivent TC(TM) TransCatheter Ventricular Enhancement Treatment
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Sep 2017
BioVentrix announces the 1st Revivent TC(TM) TransCatheter Ventricular Enhancement procedure for Ischemic Cardiomyopathy treatment at the University Heart Center Zurich in Switzerland
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Aug 2017
BioVentrix Announces First Patient Enrolled in IDE Study of the Revivent TC(TM) TransCatheter Ventricular Enhancement Treatment for Ischemic Cardiomyopathy
Devices Cardiology
 HSMN NewsFeed - 13 Mar 2017
BioVentrix announces the 1st Revivent TC(TM) TransCatheter commercial procedure to treat Ischemic Cardiomyopathy in China
Devices Cardiology
 HSMN NewsFeed - 6 Feb 2017
BioVentrix Announces NUB Reimbursement Status 1 for Revivent TC(TM) TransCatheter Ventricular Enhancement System in Germany
Devices Interventional Cardiology Reimbursement
 HSMN NewsFeed - 19 Dec 2016
BioVentrix Announces the 1st Revivent TC(TM) TransCatheter Ventricular Enhancement Procedure in Germany After Receiving CE-Mark Certification
Devices Interventional Cardiology
 HSMN NewsFeed - 31 May 2016
BioVentrix receives FDA IDE Approval for its Pivotal Clinical Trial, ALIVE
Devices Interventional Cardiology FDA
Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.